โรคข้ออักเสบไม่ทราบสาเหตุในเด็ก หรือ juvenile idiopathic arthritis (JIA) เป็นการรวมกันของข้ออักเสบที่มีลักษณะแตกต่างกันซึ่งเกิดขึ้นโดยไม่ทราบส

โครงการวิจัยนี้เป็นส่วนหนึ่งของกระบวนการพัฒนาชุดสิทธิประโยชน์ ภายใต้ระบบหลักประกันสุขภาพถ้วนหน้าของประเทศไทย ซึ่งการจี

การประเมินความคุ้มค่าแบบ Distributional Cost-Effectiveness Analysis (DCEA) เป็นการประเมินความคุ้มค่ารูปแบบใหม่ ที่ผนวกประเด็นความไม่เสมอภาค เข้าเป็นส่วน

There is increasing impetus to use pharmaceutical interventions, ie, ranibizumab or bevacizumab, for the treatment of particular macular diseases. This study conducts the evidence synthesis to inform policy decision-making of the National List of Essential Medicines Committee that recently announced the inclusion of bevacizumab for the treatment of

Alcohol addiction has been identified as one of the leading causes of disability adjusted life years in Thailand. This umbrella review aims to provide a comprehensive overview of the interventions that are effective in the prevention and treatment of harmful alcohol use, and to provide a comparison with existing interventions provided in Thailand.

This study aimed to survey experience, knowledge, importance, training needs and barriers of economic evaluation and to estimate the current human capacity and gaps in economic evaluation among researchers and policymakers in both the public and private sectors in Thailand. Based on the results, it was found that researchers, healthcare personnel,

Capacity building aims at expanding researchers’ competence and capacity, and consists of 3 approaches as follows: a. Increasing the number of mentorships by selecting highly equipped Ph.D. graduates who have made a commitment to participate in HITAP, and to increase the experience and transfer of knowledge to young researchers in an apprenticesh

Ministry of Public Health, the Royal Thai Government, has been entrusted by the World Health Organization (WHO) to co-host the First Global Forum on Medical Devices, scheduled to take place September 9th-11th, 2010, at the Hotel Plaza Athenee, Bangkok. The event attracted over 300 stakeholders, such as policy makers, scholars and health professiona

\"First Step”, a program evaluation report, assessing HITAP’s two-year efforts and providing recommendations for further development of HITAP. This program evaluation was conducted by four external evaluators including Prof. John Cairns, Dr. Kalipso Chalkidou, Prof. Paibul Suriyawongpaisal, and Dr. Jirawat Panpiemras. Moreover, Prof. Mark Sculp

The Health Intervention and Technology Assessment Program (HITAP) was established in 2007 as a non-profit organization. Its main responsibility is to assess health interventions and technology assessment with the coverage of pharmaceuticals, medical devices, interventions, individual and community health promotions and disease prevention, as well a